<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00907855</url>
  </required_header>
  <id_info>
    <org_study_id>NYU DASI 08-713</org_study_id>
    <nct_id>NCT00907855</nct_id>
  </id_info>
  <brief_title>Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests</brief_title>
  <acronym>DASI-08-713</acronym>
  <official_title>Clinical Role of the Duke Activity Status Index in the Selection of the Optimal Type of Stress Myocardial Perfusion Imaging Study in Patients With Known or Suspected Ischemic Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Astellas Pharma Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac stress testing with functional nuclear imaging is an invaluable technique in the
      diagnostic and prognostic evaluation of patients with known or suspected ischemic heart
      disease. Selection of the appropriate type of nuclear stress test: exercise stress Myocardial
      Perfusion Imaging (MPI) versus pharmacologic stress MPI is crucial for not only diagnostic
      accuracy and prognostic evaluation, but also for sound clinical decisions and resource
      utilization.

      The Duke Activity Status Index (DASI) is a 12-item questionnaire that utilized self-reported
      physical work capacity to estimate peak metabolic equivalents (METs) and has been shown to be
      a valid measurement of functional capacity. The investigators hypothesized that the DASI may
      be the screening tool that evaluates functional capacity and guides selection of the optimal
      stress MPI study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">200</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred by their primary physician to the Nuclear Lab at NYU School of Medicine
        for stress myocardial perfusion imaging testing.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer H. Mieres, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, New York University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lawrence Phillips, MD</last_name>
    <role>Study Director</role>
    <affiliation>Division of Cardiology, New York University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nuclear Cardiology/Stress Lab, NYU Cardiology Division</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Shaw LJ, Olson MB, Kip K, Kelsey SF, Johnson BD, Mark DB, Reis SE, Mankad S, Rogers WJ, Pohost GM, Arant CB, Wessel TR, Chaitman BR, Sopko G, Handberg E, Pepine CJ, Bairey Merz CN. The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol. 2006 Feb 7;47(3 Suppl):S36-43.</citation>
    <PMID>16458169</PMID>
  </reference>
  <reference>
    <citation>Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989 Sep 15;64(10):651-4.</citation>
    <PMID>2782256</PMID>
  </reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2009</study_first_submitted>
  <study_first_submitted_qc>May 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2009</study_first_posted>
  <last_update_submitted>November 29, 2011</last_update_submitted>
  <last_update_submitted_qc>November 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York University School of Medicine</investigator_affiliation>
    <investigator_full_name>Lawrence Phillips, MD</investigator_full_name>
    <investigator_title>Director, Nuclear Cardiology</investigator_title>
  </responsible_party>
  <keyword>Ischemic Heart Disease</keyword>
  <keyword>Duke Activity Status Index</keyword>
  <keyword>Stress Myocardial Perfusion Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

